Inventor
GRAY GARY S
US31 patents
⚠️ This page may combine multiple inventors who share the name “GRAY GARY S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
6 patentsUS5942607AAug 24, 1999
B7-2: a CTLA4/CD28 ligand
DANA FARBER CANCER INST INC106 citations98
US5861310AJan 19, 1999
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
DANA FARBER CANCER INST INC97 citations98
US6130316AOct 10, 2000
Fusion proteins of novel CTLA4/CD28 ligands and uses therefore
DANA FARBER CANCER INST INC64 citations95
US6824779B1Nov 30, 2004
Methods for inhibiting the interaction of B7-2 with its natural ligand
DANA FARBER CANCER INST INC20 citations93
US6084067AJul 4, 2000
CTLA4/CD28 ligands and uses therefor
DANA FARBER CANCER INST INC31 citations93
US7592007B2Sep 22, 2009
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies
DANA FARBER CANCER INST INC2 citations61
GENETICS INST LLC
5 patentsUS7232566B2Jun 19, 2007
Methods for treating HIV infected subjects
GENETICS INST LLC814 citations99
US7479269B2Jan 20, 2009
Methods for selectively enriching TH1 and TH2 cells
GENETICS INST LLC32 citations93
US7459544B2Dec 2, 2008
Nucleic acids encoding B7-2 fusion proteins
GENETICS INST LLC1 citations63
US7666421B2Feb 23, 2010
Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2
GENETICS INST LLC0 citations51
US7531175B2May 12, 2009
Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
GENETICS INST LLC1 citations51
US NAVY
5 patentsUS7175843B2Feb 13, 2007
Methods for selectively stimulating proliferation of T cells
US NAVY821 citations99
US7144575B2Dec 5, 2006
Methods for selectively stimulating proliferation of T cells
US NAVY799 citations99
US6905680B2Jun 14, 2005
Methods of treating HIV infected subjects
US NAVY879 citations99
US6887466B2May 3, 2005
Methods for selectively stimulating proliferation of T cells
US NAVY914 citations99
US5858358AJan 12, 1999
Methods for selectively stimulating proliferation of T cells
US NAVY885 citations99
INST GENETICS LLC
5 patentsUS6905681B1Jun 14, 2005
Methods for selectively stimulating proliferation of T cells
INST GENETICS LLC913 citations99
US6913747B1Jul 5, 2005
Humanized immunoglobulin reactive with B7 therewith
INST GENETICS LLC80 citations98
US6984383B1Jan 10, 2006
Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins
INST GENETICS LLC57 citations95
US6827934B1Dec 7, 2004
Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith
INST GENETICS LLC17 citations92
US6972125B2Dec 6, 2005
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
INST GENETICS LLC8 citations73
GENETICS INST
4 patentsUS6534055B1Mar 18, 2003
Methods for selectively stimulating proliferation of T cells
GENETICS INST1,025 citations99
US6352694B1Mar 5, 2002
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
GENETICS INST1,159 citations99
US6605279B2Aug 12, 2003
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands
GENETICS INST43 citations96
US6613327B1Sep 2, 2003
Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal
GENETICS INST6 citations69
REPLIGEN CORP
3 patentsUS6719972B1Apr 13, 2004
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies
REPLIGEN CORP126 citations97
US6444792B1Sep 3, 2002
CTLA4-Cγ4 fusion proteins
REPLIGEN CORP194 citations96
US6750334B1Jun 15, 2004
CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor
REPLIGEN CORP104 citations95